Kras Kickers at the 2020 National Lung Cancer Round Table 

KRas Kickers will be attending the 2020 National Lung Cancer Roundtable to represent the 25% of the lung cancer patients with a Kirsten rat sarcoma (KRAS) mutation. A comprehensive biomarker test should be completed by a doctor to identify cancer mutations.

Three of the four most deadly U.S. cancers (lung, colon and pancreatic) have a KRAS mutation. There are no specific drugs for KRAS cancers, more research is crucial. is a patient driven conduit advocating for treatments, sharing knowledge & clinical trials for KRAS lung cancer patients pleading to Kick Cancers K Ras!!


Be the first to find out about medical breakthroughs, clinical trials, events, and more.

We do not sell or share your email address with anyone.

This website is not intended to, and does not, provide medical advice, professional diagnosis, opinion, treatment, or services. Medical information provided on this site is for informational and educational purposes only. After reading content from this website, you are encouraged to review the information carefully with your physician.

Privacy Policy

©2021 KRAS Cancer Connect, Inc. Web Design by